Kari Gillmeyer MD

Assistant Professor, Pulmonary, Allergy, Sleep & Critical Care Medicine

72 E. Concord Street | (617) 358-2800
Kari Gillmeyer
Sections

Pulmonary, Allergy, Sleep & Critical Care Medicine

Centers

Pulmonary Center

Biography

Dr. Gillmeyer is a health services researcher with a career dedicated to improving quality of care and outcomes for vulnerable patients. Dr. Gillmeyer’s work focuses on pulmonary hypertension, a devastating, progressive disease that exerts a heavy burden on patients and health systems. Through her research, Dr. Gillmeyer hopes to improve the quality, safety, and equity of pulmonary hypertension care and to mitigate health disparities in pulmonary hypertension.

Education

Medicine, MD, University of Minnesota Medical School, 2012

Biology, BS, South Dakota State University, 2007

Publications

Published on 9/1/2021

Garcia MA, Rampon GL, Doros G, Jia S, Jagan N, Gillmeyer K, Berical A, Hudspeth J, Ieong M, Modzelewski KL, Schechter-Perkins EM, Ross CS, Rucci JM, Simpson S, Walkey AJ, Bosch NA. Rationale and Design of the Awake Prone Position for Early Hypoxemia in COVID-19 Study Protocol: A Clinical Trial. Ann Am Thorac Soc. 2021 09; 18(9):1560-1566. PMID: 33647225.

Published on 4/1/2021

Gillmeyer KR, Miller DR, Glickman ME, Qian SX, Klings ES, Maron BA, Hanlon JT, Rinne ST, Wiener RS. Outcomes of pulmonary vasodilator use in Veterans with pulmonary hypertension associated with left heart disease and lung disease. Pulm Circ. 2021 Apr-Jun; 11(2):20458940211001714. PMID: 33868640.

Published on 12/17/2020

Gillmeyer KR, Nunez ER, Rinne ST, Qian SX, Klings ES, Wiener RS. Development and Validation of Algorithms to Identify Pulmonary Arterial Hypertension in Administrative Data. Chest. 2021 May; 159(5):1986-1994. PMID: 33345949.

Published on 9/15/2020

Lui JK, Bosch NA, Gillmeyer KR, Reardon CC. Novel Therapeutic Approaches for Pulmonary Manifestations of Systemic Sclerosis. Am J Respir Crit Care Med. 2020 09 15; 202(6):878-880. PMID: 32574505.

Published on 6/1/2020

Gillmeyer KR, Rinne ST, Walkey AJ, Qian SX, Wiener RS. How Closely Do Clinical Trial Participants Resemble "Real-World" Patients with Groups 2 and 3 Pulmonary Hypertension? A Structured Review. Ann Am Thorac Soc. 2020 06; 17(6):779-783. PMID: 32150687.

Published on 5/12/2020

Gillmeyer KR, Rinne ST, Glickman ME, Lee KM, Shao Q, Qian SX, Klings ES, Maron BA, Hanlon JT, Miller DR, Wiener RS. Factors Associated With Potentially Inappropriate Phosphodiesterase-5 Inhibitor Use for Pulmonary Hypertension in the United States, 2006 to 2015. Circ Cardiovasc Qual Outcomes. 2020 05; 13(5):e005993. PMID: 32393128.

Published on 8/1/2019

Gillmeyer KR, Lee KM, Shao Q, Miller DR, Maron BA, Klings ES, Rinne ST, Wiener RS. Multisystem Healthcare Use among U.S. Veterans with Pulmonary Hypertension. Ann Am Thorac Soc. 2019 08; 16(8):1072-1074. PMID: 31026406.

Published on 5/1/2019

Gillmeyer KR, Lee MM, Link AP, Klings ES, Rinne ST, Wiener RS. Response. Chest. 2019 05; 155(5):1077-1078. PMID: 31060692.

Published on 11/22/2018

Gillmeyer KR, Lee MM, Link AP, Klings ES, Rinne ST, Wiener RS. Accuracy of Algorithms to Identify Pulmonary Arterial Hypertension in Administrative Data: A Systematic Review. Chest. 2019 04; 155(4):680-688. PMID: 30471268.

View full list of 9 publications.